Q4 2017 Holdings
Filed 2018-02-05 | 12 holdings | $138.3K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Paratek Pharmaceuticals | Common Stock | 699374302 | $46.5K | 2,600,410 | 33.7% |
| Juno Therapeutics | Common Stock | 48205A109 | $34.4K | 753,564 | 24.9% |
| Sienna Biopharmaceuticals(SNNAQ) | Common Stock | 82622H108 | $13.8K | 758,610 | 10.0% |
| ObsEva | Common Stock | H5861P103 | $9.8K | 1,000,000 | 7.1% |
| Jounce Therapeutics(JNCEEUR) | Common Stock | 481116101 | $7.4K | 579,650 | 5.3% |
| Pieris Pharmaceuticals | Common Stock | 720795103 | $6.8K | 904,053 | 4.9% |
| FibroGen(FGENEUR) | Common Stock | 31572Q808 | $6.2K | 130,646 | 4.5% |
| CymaBay Therapeutics(CBAYUSD) | Common Stock | 23257D103 | $5.1K | 551,477 | 3.7% |
| Cidara Therapeutics | Common Stock | 171757107 | $3.0K | 444,965 | 2.2% |
| Egalet | Common Stock | 28226B104 | $2.9K | 2,889,926 | 2.1% |
| Dicerna Pharmaceuticals(DRNAUSD) | Common Stock | 253031108 | $2.0K | 223,457 | 1.5% |
| Essa Pharma | Common Stock | 29668H104 | $373 | 1,696,969 | 0.3% |